-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Acute myeloid leukemia (AML) patients undergoing intensive chemotherapy not only face life-threatening diseases, require isolation and hospitalization, but also have many physical and psychological symptoms .
Acute myeloid leukemia (AML) patients receiving intensive chemotherapy not only face life-threatening diseases, need to be isolated and hospitalized, but also have many physical and psychological symptoms
Amonoo et al.
Among the 160 patients, 28% reported PTSD symptoms , and had a high rate of invasion, evasion, and high alertness.
28% of patients reported PTSD symptoms
The incidence of PTSD symptoms in patients with different coping styles
The incidence of PTSD symptoms in patients with different coping stylesThe baseline sociodemographic factors significantly related to PTSD symptoms were age (B=-0.
The baseline sociodemographic factors significantly related to PTSD symptoms were age (B=-0.
The patient’s baseline quality of life, coping strategies, and the degree of decline in quality of life during hospitalization are all important risk factors for post-traumatic stress disorder
Original source:
Original source:Amonoo Hermioni L, LeBlanc Thomas W, Kavanaugh Alison R et al.
org/10.
1002/cncr.
33524" target="_blank" rel="noopener">Posttraumatic stress disorder (PTSD) symptoms in patients with acute myeloid leukemia (AML) in this message